Form D · Biotechnology

BRAIN TUNNELGENIX TECHNOLOGIES CORP

Aventura, FL · CIK 0001489454

Offering snapshot reported Jun 22, 2022 · SEC filing

Reported sold
$5M
Offering amount: $5M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 8, 2022
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 22, 2022Initial$5,000,000No comparison1SEC filing
Jan 7, 2022Initial$29,299,991No comparison1SEC filing
Dec 11, 2015Initial$9,149,015No comparison15SEC filing
Sep 17, 2013Initial$2,213,168No comparison1SEC filing
May 14, 2013Initial$100,000No comparison1SEC filing
Apr 16, 2010Initial$250,000No comparison3SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-449961

Source: Form D, filed Jun 22, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Marc Abreu Director
Marcio Marc Aurelio Martins Abreu Director, Executive
Marcio Aurelio Martins Abreu Director, Executive
Maria Altieri Director, Executive
Paul Anthony Caiafa Director, Executive
Anthony Raymond De Chello Executive
Rick Allen Foreman Director
Robert J. Mogel Director, Executive
Joseph Roger Titone Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
17501 Biscayne Blvd. Suite 470
Aventura, FL, 33160